PRECIGEN THERAPEUTICS Trademark

Trademark Overview


On Friday, March 10, 2017, a trademark application was filed for PRECIGEN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PRECIGEN THERAPEUTICS trademark a serial number of 87366778. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 28, 2022. This trademark is owned by Intrexon Corporation. The PRECIGEN THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Chemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; biochemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; chemical reagents for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders

Chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene expression

Technology transfer services, namely, licensing of intellectual property

Medical services; Medical services, namely, genetic engineering, biopharmaceuticals and gene therapy services; Healthcare services, namely, treatment of patients with genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; Medical services, namely, providing medical therapy treatments which are under development or have completed development for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases

Scientific research and development services in the field of medicine, pharmacology, immunology, biochemistry, cell biology, genetics, microbiology and virology; Scientific research in the field of healthcare; Therapeutic research of treatments in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular disease which are under development or have completed development; Development of products being genetic therapies, biopharmaceuticals, and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Research and development services for others in the fie...
precigen therapeutics

General Information


Serial Number87366778
Word MarkPRECIGEN THERAPEUTICS
Filing DateFriday, March 10, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 28, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2019

Trademark Statements


Goods and ServicesChemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; biochemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; chemical reagents for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders
Goods and ServicesChemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene expression
Goods and ServicesTechnology transfer services, namely, licensing of intellectual property
Goods and ServicesMedical services; Medical services, namely, genetic engineering, biopharmaceuticals and gene therapy services; Healthcare services, namely, treatment of patients with genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; Medical services, namely, providing medical therapy treatments which are under development or have completed development for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesScientific research and development services in the field of medicine, pharmacology, immunology, biochemistry, cell biology, genetics, microbiology and virology; Scientific research in the field of healthcare; Therapeutic research of treatments in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular disease which are under development or have completed development; Development of products being genetic therapies, biopharmaceuticals, and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Research and development services for others in the fields of genetics and biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, March 16, 2017
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 16, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 16, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 16, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 16, 2017
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePRECIGEN, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060

Party NamePrecigen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060

Party NameIntrexon Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBlacksburg, VA 24060

Trademark Events


Event DateEvent Description
Wednesday, February 7, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 7, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, November 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 31, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 31, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 31, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 31, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 12, 2022SOU EXTENSION 5 GRANTED
Friday, April 8, 2022SOU EXTENSION 5 FILED
Friday, April 8, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 20, 2021SOU EXTENSION 4 GRANTED
Wednesday, October 20, 2021SOU EXTENSION 4 FILED
Wednesday, October 20, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 20, 2021SOU EXTENSION 3 GRANTED
Tuesday, April 20, 2021SOU EXTENSION 3 FILED
Tuesday, April 20, 2021SOU TEAS EXTENSION RECEIVED
Saturday, October 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 15, 2020SOU EXTENSION 2 GRANTED
Thursday, October 15, 2020SOU EXTENSION 2 FILED
Thursday, October 15, 2020SOU TEAS EXTENSION RECEIVED
Saturday, April 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 10, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 8, 2020SOU EXTENSION 1 FILED
Friday, April 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 8, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, April 8, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 22, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 19, 2019ASSIGNED TO LIE
Wednesday, July 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 21, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, June 21, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 21, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, December 21, 2017LETTER OF SUSPENSION E-MAILED
Thursday, December 21, 2017SUSPENSION LETTER WRITTEN
Wednesday, December 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 5, 2017NON-FINAL ACTION E-MAILED
Monday, June 5, 2017NON-FINAL ACTION WRITTEN
Monday, June 5, 2017ASSIGNED TO EXAMINER
Thursday, March 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 14, 2017NEW APPLICATION ENTERED